Cytoreductive Surgery Is the Best Way to Affect Survival Outcomes
Renee A. Cowan, MD, MPH
Advertisement
Articles by Renee A. Cowan, MD, MPH
Advertisement
Latest Updated Articles
POINT: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian CancerPublished: June 15th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
3
FDA Approves Revumenib in R/R NPM1-Mutant AML
4
Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC
5
